Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Bullboard Posts
Post by Sonny7on Dec 02, 2020 6:09pm
388 Views
Post# 32023030

Going Forward

Going ForwardTiming is right to show some meat on the VPT bones, so to speak. The month of November showed pieces of news related to the hiring of an IR firm, although Mr Adams seems to have a dislike for IR types citing lack of performance. It must have been the other guys. ...  Also announced VMS installations. Then there was settling the business of shares for debt and of course, quarterly reports with MD&A outlining the company’s activities and projections up to THE END OF SEPTEMBER!! Two Months in Passing! Anyone knowing Dr Adams will understand he is busy behind the scenes at all times and my belief is that in the past two months he has created more to report since the end of September. He has more up his sleeve than his arm, methinks. 

As I see it, November news has cleared the bone from VPT’s throat, so to speak, and with the “fluff” news out of the way, the optimistic side of me believes that the company will offer us news to show some revenue generating events. I can’t see it NOT happening. To me, timing seems right for it. It shouldn’t be hard to figure out that the company is “Right There” with all approvals in place for World Wide use. 

December should take take us to a new level with the right news to have the share price run over the sellers who are intent on holding the share price down. We should be at a new higher level before Christmas. .......and that’s the bad news!!

With VPT technology proven up but yet in It’s infancy, big Multinational Medical Device companies will want/need to own our shares. They will come to slap us silly with their check books in a buyout. 
We will wait and see. 
my opinion
Bullboard Posts